Compare WLDN & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLDN | CDNA |
|---|---|---|
| Founded | 1964 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2006 | 2007 |
| Metric | WLDN | CDNA |
|---|---|---|
| Price | $87.00 | $49.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $114.50 | $28.00 |
| AVG Volume (30 Days) | 201.9K | ★ 997.6K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.89 | N/A |
| EPS | 2.13 | 2.13 |
| Revenue | ★ $273,352,000.00 | $48,324,000.00 |
| Revenue This Year | N/A | $16.01 |
| Revenue Next Year | $12.05 | $11.31 |
| P/E Ratio | $40.27 | ★ $23.89 |
| Revenue Growth | N/A | ★ 18.93 |
| 52 Week Low | $64.67 | $13.39 |
| 52 Week High | $137.00 | $53.67 |
| Indicator | WLDN | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 62.04 |
| Support Level | $72.52 | $45.74 |
| Resistance Level | $88.72 | $53.67 |
| Average True Range (ATR) | 2.85 | 2.51 |
| MACD | -0.15 | -0.44 |
| Stochastic Oscillator | 74.81 | 59.21 |
Willdan Group Inc is a technical services company focused on energy and infrastructure solutions. The company's solutions include energy planning and analytics, consulting, software, public finance, engineering, and program implementation. It operates through two segments: i) Energy segment: It provides specialized, comprehensive energy solutions to businesses, utilities, state agencies, municipalities, and non-profit organizations. ii) Engineering & Consulting: It provides civil engineering and construction management, building and safety services, city engineering and planning support, civil design, geotechnical services, and material testing. The majority of revenue is derived from the Energy segment. Geographically, all of the company's revenue is generated from the United States.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.